Clinical Trial Update: Avelumab and Radiation in Muscle-Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating avelumab with radiation for muscle-invasive bladder cancer was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Bladder Cancer, Muscle Invasive Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2025-10-31